Por favor, inténtelo con una nueva búsqueda
Nombre | Edad | Desde | Título |
---|---|---|---|
Philip Wagenheim | 53 | 2017 | Director |
Shmuel Shoham | - | 2020 | Member of COVID-19 Advisory Board |
John M. Lambert | 73 | 2023 | Member of Antibody-Drug Conjugate & T Cell Redirection Advisory Board |
Louis M. Weiner | 72 | - | Member of Scientific Advisory Board |
Jeffrey Henderson | - | 2020 | Member of COVID-19 Advisory Board |
Isaac Barchas | 57 | 2023 | Lead Independent Director |
Susan Weiss | - | 2020 | Member of COVID-19 Advisory Board |
Andrew D. Badley | - | 2021 | Member of COVID-19 Advisory Board |
Jean-Jacques Bienaime | 71 | 2023 | Independent Director |
James Patrick Boylan | 56 | 2023 | Independent Director |
William Strohl | 71 | - | Member of Scientific Advisory Board |
Anthony W. Tolcher | - | - | Member of Scientific Advisory Board and Member of ADC & T Cell Redirection Advisory Board |
George C. Prendergast | - | - | Member of Scientific Advisory Board |
Clay B. Siegall | 63 | 2023 | President, CEO & Chairman |
Carol A. Schafer | 60 | 2024 | Independent Director |
Sandra M. Swain | 69 | 2024 | Independent Director |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores